Manufacturers Life Insurance Company, The Vertex Pharmaceuticals Inc Transaction History

Manufacturers Life Insurance Company, The

  • $103 Billion
  • Q1 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 695,825 shares of VRTX stock, worth $326 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
695,825
Previous 818,803 15.02%
Holding current value
$326 Million
Previous $333 Million 12.7%
% of portfolio
0.28%
Previous 0.33%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $50.1 Million - $54.9 Million
-122,978 Reduced 15.02%
695,825 $291 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $21.5 Million - $25.8 Million
-62,702 Reduced 7.11%
818,803 $333 Million
Q3 2023

Nov 15, 2023
SELL
$338.18 - $362.46 $15.9 Million - $17 Million
-46,912 Reduced 5.05%
881,505 $307 Million
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $28.2 Million - $31.5 Million
89,554 Added 10.68%
928,417 $327 Million
Q1 2023

May 15, 2023
BUY
$283.23 - $323.1 $20.8 Million - $23.7 Million
73,423 Added 8.75%
912,286 $287 Million
Q4 2022

Aug 11, 2023
BUY
$285.76 - $321.48 $24.9 Million - $28 Million
86,980 Added 11.57%
838,863 $242 Million
Q4 2022

Feb 13, 2023
BUY
$285.76 - $321.48 $24.9 Million - $28 Million
86,980 Added 11.57%
838,863 $242 Million
Q3 2022

Aug 11, 2023
BUY
$273.83 - $305.53 $571,757 - $637,946
2,088 Added 0.28%
751,883 $218 Million
Q3 2022

Nov 03, 2022
BUY
$273.83 - $305.53 $571,757 - $637,946
2,088 Added 0.28%
751,883 $218 Million
Q2 2022

Aug 11, 2023
BUY
$234.96 - $292.55 $26.1 Million - $32.5 Million
111,201 Added 17.41%
749,795 $211 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $26.1 Million - $32.5 Million
111,201 Added 17.41%
749,795 $211 Million
Q1 2022

Aug 11, 2023
SELL
$221.42 - $260.97 $60.6 Million - $71.4 Million
-273,692 Reduced 30.0%
638,594 $167 Million
Q1 2022

May 20, 2022
BUY
$221.42 - $260.97 $35.8 Million - $42.2 Million
161,674 Added 33.9%
638,594 $166 Million
Q4 2021

Feb 16, 2022
SELL
$177.01 - $223.45 $20.5 Million - $25.9 Million
-116,047 Reduced 19.57%
476,920 $105 Million
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $1.05 Million - $1.17 Million
-5,773 Reduced 0.96%
592,967 $108 Million
Q2 2021

Aug 12, 2021
SELL
$187.49 - $221.1 $1.84 Million - $2.17 Million
-9,815 Reduced 1.61%
598,740 $121 Million
Q1 2021

May 03, 2021
BUY
$207.02 - $241.31 $37.2 Million - $43.4 Million
179,847 Added 41.95%
608,555 $131 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $38 Million - $50.6 Million
183,432 Added 74.79%
428,708 $101 Million
Q3 2020

Nov 09, 2020
SELL
$255.65 - $303.1 $8.04 Million - $9.53 Million
-31,450 Reduced 11.37%
245,276 $66.7 Million
Q2 2020

Aug 10, 2020
SELL
$225.48 - $295.8 $660,205 - $866,102
-2,928 Reduced 1.05%
276,726 $78.9 Million
Q1 2020

May 15, 2020
BUY
$199.77 - $247.81 $7.66 Million - $9.5 Million
38,355 Added 15.9%
279,654 $66.5 Million
Q4 2019

Feb 14, 2020
SELL
$166.71 - $223.91 $1.18 Million - $1.58 Million
-7,069 Reduced 2.85%
241,299 $52.8 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $1.56 Million - $1.76 Million
9,405 Added 3.94%
248,368 $41.4 Million
Q2 2019

Aug 14, 2019
SELL
$164.61 - $190.37 $3.68 Million - $4.25 Million
-22,329 Reduced 8.55%
238,963 $43.8 Million
Q1 2019

May 13, 2019
SELL
$163.73 - $194.7 $6.87 Million - $8.17 Million
-41,987 Reduced 13.84%
261,292 $48.1 Million
Q4 2018

Feb 14, 2019
SELL
$151.91 - $192.21 $2.03 Million - $2.57 Million
-13,370 Reduced 4.22%
303,279 $50.3 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $7.5 Million - $8.62 Million
44,742 Added 16.45%
316,649 $61 Million
Q2 2018

Aug 14, 2018
BUY
$145.72 - $169.96 $3.45 Million - $4.03 Million
23,694 Added 9.55%
271,907 $46.2 Million
Q1 2018

May 15, 2018
SELL
$151.6 - $177.13 $9.88 Million - $11.5 Million
-65,168 Reduced 20.8%
248,213 $40.5 Million
Q4 2017

Feb 08, 2018
BUY
$137.28 - $155.55 $4.61 Million - $5.23 Million
33,614 Added 12.01%
313,381 $47 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $41.4 Million - $45.4 Million
279,767
279,767 $42.5 Million

Others Institutions Holding VRTX

# of Institutions
1,623
Shares Held
222M
Call Options Held
1.35M
Put Options Held
1.49M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email